17,520 resources
By Version
By Realm
Start Prev Rows 1000 - 1200 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Realm | Source(s) |
---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.771 | Cyanosis SCT | active | 2023-12 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.772 | Cyanosis | active | 2023-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.775 | Arterial oxygen saturation LOINC | active | 2024-09 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.776 | Arterial oxygen saturation SCT | active | 2024-08 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.777 | Arterial oxygen saturation | active | 2024-08 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.779 | PIM_Potassium_Supplements | active | 2024-03 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.780 | PIM_PPIs | active | 2024-03 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.781 | PIM_Migraine_Medications_Abortive | active | 2024-03 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.782 | PIM_Migraine_Medications_Preventive | active | 2024-03 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.783 | PIM_Bisphosphonates | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.784 | PIM_BPH_Medications | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.785 | PIM_Thyroid_Replacement_Medications | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.786 | PIM_Overactive_Bladder_Medications | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.787 | PIM_Topical_Acne_Medications | active | 2024-03 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.788 | PIM_Antidepressant_Anxiolytic_Medications | active | 2024-01 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.789 | Simple Knee Pain I10 | active | 2024-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.790 | Simple Knee Pain SCT | active | 2024-01 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.791 | Simple Knee Pain | active | 2024-01 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.792 | Simple Left Knee Pain SCT | active | 2024-01 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.793 | Simple Right Knee Pain SCT | active | 2024-01 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.794 | Simple Right Knee Pain I10 | active | 2024-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.795 | Simple Left Knee Pain I10 | active | 2024-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.796 | Simple Right Knee Pain | active | 2024-01 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.797 | Simple Left Knee pain | active | 2024-01 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.798 | Knee joint surgery CPT | active | 2024-01 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.799 | Knee joint surgery SCT | active | 2024-01 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.800 | Knee joint surgery | active | 2024-01 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.801 | Knee Osteoarthritis I10 | active | 2024-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.802 | Knee Osteoarthritis SCT | active | 2024-01 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.803 | Knee Osteoarthritis | active | 2024-01 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.804 | Osteoarthritis of right knee SCT | active | 2024-01 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.805 | Osteoarthritis of left knee SCT | active | 2024-01 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.806 | Osteoarthritis of right knee I10 | active | 2024-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.807 | Osteoarthritis of left knee I10 | active | 2024-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.808 | Osteoarthritis of right knee | active | 2024-01 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.809 | Osteoarthritis of left knee | active | 2024-01 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.810 | Hip Osteoarthritis SCT | active | 2024-01 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.811 | Hip Osteoarthritis I10 | active | 2024-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.812 | Hip Osteoarthritis | active | 2024-01 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.813 | Hip joint surgery CPT | active | 2024-01 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.814 | Hip joint surgery SCT | active | 2024-01 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.815 | Hip joint surgery | active | 2024-01 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.816 | Osteoarthritis of right hip I10 | active | 2024-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.817 | Osteoarthritis of left hip I10 | active | 2024-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.818 | Osteoarthritis of right hip SCT | active | 2024-01 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.819 | Osteoarthritis of left hip SCT | active | 2024-01 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.820 | Osteoarthritis of right hip | active | 2024-01 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.821 | Osteoarthritis of left hip | active | 2024-01 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.823 | Aminoglycosides | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.824 | Carbapenems | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.826 | Monobactams | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.827 | Penicillins | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.828 | Antimycobacterials | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.829 | Beta_lactamase | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.830 | Cyclic lipopeptides | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.831 | Lincosamides | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.832 | Macrolides | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.833 | Amphenicol | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.834 | Oxazolidinones | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.835 | Fluoroquinolones | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.836 | Sulfonamides | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.837 | Tetracyclines | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.838 | Phosphonics | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.839 | Pleuromutilin | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.840 | Streptogramins | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.841 | Lipoglycopeptides | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.842 | Nitroimidazoles | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.843 | PIM_Hyd_Bus_Mir_Tra | active | 2024-02 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.844 | Nitrofurans | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.845 | Rifamycins | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.846 | Glycylcycline | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.847 | Pyrimidines | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.849 | Antibiotics oral and parenteral | active | 2024-02 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.850 | Medications_hyperkalemia | active | 2024-03 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.852 | Hyperkalemia_ICD10 | active | 2024-02 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.853 | Hyperkalemia_SCT | active | 2024-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.854 | Hyperkalemia Conditions | active | 2024-02 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.855 | Medications_Chronic Hyperkalemia | active | 2024-02 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.858 | PIM_Alpha_Blockers_2 | active | 2024-03 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.860 | PIM_Ambulatory_Visits_CPTs | active | 2024-03 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.862 | PIM_Ambulatory_Visits_SNOMED | active | 2024-03 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.863 | PIM_Thyroid_Stimulating_Hormone_(TSH) | active | 2024-03 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.864 | PIM_Triiodothyronine_(T3) | active | 2024-03 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.865 | PIM_Thyroxine_(T4) | active | 2024-03 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.866 | PIM_Magnesium_LOINC | active | 2024-03 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.867 | PIM_BMP_CMP_LOINC | active | 2024-03 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.868 | PIM_URIC_ACID_LOINC | active | 2024-03 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.869 | PIM_Migraine_Medications | active | 2025-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.870 | PIM_Triptans | active | 2024-03 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.871 | ICS_SABA Reliever | active | 2024-06 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.873 | PIM_Asthma_COPD_Meds | active | 2025-03 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.874 | PIM_Lipid_Panel_CPTs | active | 2024-03 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.875 | PIM_Hepatic_Function_Panel_CPTs | active | 2024-03 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.876 | Alpha Glucosidase Allergy Intolerance | active | 2025-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.877 | Inflammatory bowel disease I10 | active | 2024-04 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.878 | Inflammatory bowel disease SCT | active | 2024-04 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.879 | Inflammatory bowel disease | active | 2024-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.880 | Gastrointestinal obstruction SCT | active | 2024-04 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.881 | Gastrointestinal obstruction I10 | active | 2024-04 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.882 | Gastrointestinal obstruction | active | 2024-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.883 | DPP4i Allergy Intolerance | active | 2025-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.884 | Multiple endocrine neoplasia type 2 (MEN II) SCT | active | 2024-04 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.885 | Multiple endocrine neoplasia type 2 (MEN II) I10 | active | 2024-04 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.886 | Multiple endocrine neoplasia type 2 (MEN II) | active | 2024-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.887 | Gastroparesis SCT | active | 2024-04 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.888 | Gastroparesis I10 | active | 2024-04 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.889 | Gastroparesis | active | 2024-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.890 | Meglitinide Allergy Intolerance | active | 2025-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.891 | Sulfonylurea Allergy Intolerance | active | 2025-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.892 | Peripheral edema I10 | active | 2024-04 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.893 | Peripheral edema SCT | active | 2024-04 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.894 | Peripheral edema | active | 2024-04 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.895 | TZD Allergy Intolerance | active | 2025-05 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.896 | PIM_Beta_Blockers | active | 2024-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.897 | PIM_CCB_DHPs | active | 2024-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.898 | PIM_Loop_Diuretics | active | 2024-04 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.899 | PIM_Inhaled_Corticosteroids_(ICS) | active | 2025-03 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.9 | ACE inhibitors | active | 2024-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.90 | ASCVD I10 | active | 2023-09 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.900 | PIM_Leukotrienes | active | 2024-04 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.901 | OIA_Asthma_COPD_Meds_Inhalers | active | 2025-04 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.902 | OIA_Asthma_COPD_Meds_Nebulizers | active | 2024-04 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.903 | OIA_Asthma_COPD_Meds_Oral | active | 2024-04 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.904 | OIA_GLP1_Injectables | active | 2024-04 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.905 | OIA_Insulin_Injectables | active | 2024-04 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.906 | OIA_Oral_Hypoglycemics | active | 2024-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.907 | OIA_DM1_DM2_Meds | active | 2024-10 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.908 | Medium Dose ICS Formoterol | active | 2024-05 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.909 | High Dose ICS Formoterol | active | 2024-05 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.910 | CKD stage5OrESRD I10 | active | 2024-05 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.911 | CKD stage5OrESRD SCT | active | 2024-05 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.912 | CKD stage5OrESRD | active | 2024-05 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.914 | Anxiety_I10 | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.915 | Anxiety_SCT | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.916 | Anxiety | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.918 | Stress_SCT | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.919 | Stress_I10 | active | 2024-06 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.920 | Stress | active | 2024-06 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.921 | PBH_Anxiety_SCT | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.922 | PBH_Depression_SCT | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.923 | PBH_Stress_SCT | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.924 | PBH_Insomnia_SCT | active | 2024-06 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.925 | PIM_CMP_CPTs | active | 2024-06 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.926 | Canagliflozin meds | active | 2024-07 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.927 | Empagliflozin meds | active | 2024-07 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.928 | Dapagliflozin meds | active | 2024-07 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.929 | Ertugliflozin meds | active | 2024-07 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.930 | Dulaglutide meds | active | 2024-07 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.931 | Liraglutide meds | active | 2024-07 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.932 | Semaglutide SC meds | active | 2024-07 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.933 | T2DM meds benefitting ASCVD | active | 2024-07 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.934 | T2DM meds benefitting CKD stages 2, 3, and 4 with eGFR >= 20 mL/min | active | 2024-07 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.935 | T2DM meds benefitting CKD stage 5 | active | 2024-07 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.936 | T2DM meds benefitting HF with eGFR >= 20 mL/min | active | 2024-07 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.938 | Crohn disease SCT | active | 2024-10 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.939 | Crohn disease I10 | active | 2024-10 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.940 | Crohn disease | active | 2024-10 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.941 | Celiac disease SCT | active | 2024-10 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.942 | Celiac disease I10 | active | 2024-10 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.943 | Celiac disease | active | 2024-10 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.944 | OIA_Bisoprolol | active | 2024-10 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.945 | OIA_PVD_ICD10 | active | 2024-10 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.946 | Vibration Controlled Transient Elastography (VCTE) | active | 2024-12 | us | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.947 | OIA_Antihypertensive_Medications | active | 2024-10 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.950 | OIA_CAD_ICD10 | active | 2024-10 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.951 | OIA_DM_ICD10 | active | 2024-10 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.952 | OIA_Creatinine_Levels_LOINC | active | 2024-10 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.953 | OIA_DM_SNOMEDCT | active | 2024-10 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.954 | OIA_CAD_SNOMEDCT | active | 2024-10 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.955 | OIA_PVD_SNOMEDCT | active | 2024-10 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.956 | OIA_DM_ICD10_SNOMEDCT | active | 2024-10 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.957 | OIA_CAD_ICD10_SNOMEDCT | active | 2024-10 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.958 | OIA_PVD_ICD10_SNOMEDCT | active | 2024-10 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.959 | ACEi for HFrEF | active | 2025-01 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.960 | ARB for HFrEF | active | 2024-12 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.961 | OIA_AntiHTN_Meds_Inclusion_List | active | 2024-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.962 | OIA_Thiazide_Diuretics | active | 2024-11 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.963 | OIA_RFs_ACS_ICD10 | active | 2024-12 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.964 | OIA_RFs_ACS_SNOMED | active | 2024-12 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.965 | OIA_RFs_ACS__ICD10_SNOMED | active | 2024-12 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.966 | OIA_Aortic_Calcifications_ICD10 | active | 2025-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.967 | OIA_Aortic_Calcifications_SNOMED | active | 2025-01 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.968 | OIA_Aortic_Calcifications_ICD10_SNOMED | active | 2025-01 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.969 | OIA_Microalbumin | active | 2025-01 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.97 | Sulfonylurea AllergyIntolerance SCT | active | 2023-09 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.970 | OIA_LDL_Cholesterol | active | 2025-01 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.971 | Pioglitazone | active | 2025-01 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.972 | MASLD I10 | active | 2025-02 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.973 | MASLD SCT | active | 2025-02 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.975 | OIA_Sulfonylureas | active | 2025-01 | us | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.978 | OIA_RFs_ASCVD_ICD10 | active | 2025-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.979 | OIA_RFs_ASCVD_SNOMED | active | 2025-01 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.98 | BMI LOINC | active | 2024-03 | us | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.980 | OIA_RFs_ASCVD_ICD10_SNOMED | active | 2025-01 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.981 | OIA_TIA_ICD10 | active | 2025-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.982 | OIA_TIA_SNOMED | active | 2025-01 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.983 | OIA_TIA_ICD10_SNOMED | active | 2025-01 | us | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.984 | OIA_Angina_ICD10 | active | 2025-01 | us | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.985 | OIA_Angina_SNOMED | active | 2025-01 | us | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.987 | OIA_Angina_ICD10_SNOMED | active | 2025-01 | us | vsac |